Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential drug targets for tumors identified through Mendelian randomization analysis.

Scientific reports - 18 May 2024

Song Na, Shi Pingyu, Cui Kai, Zeng Liqun, Wang Ziwei, Di Wenyu, Li Jinsong, Fan Yanwu, Li Zhanjun, Zhang Jinghang, Su Wei, Wang Haijun

Abstract excerpt

According to the latest cancer research data, there are a significant number of new cancer cases and a substantial mortality rate each year. Although a substantial number of clinical patients are treated with existing cancer drugs each year, the efficacy is unsatisfactory. The incidence is still high and the effectiveness of most cancer drugs remains unsatisfactory. Therefore, we evaluated the human proteins for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to MIA gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genome-Wide Association Study

Share to Mendelian Randomization Analysis

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 38762700
DOI: 10.1038/s41598-024-62178-w
PMCID: PMC11102463

Genes

MIA
PDE5A
S100A14
S100A16

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential drug targets for tumors identified through Mendelian randomization analysis.PMID 38762700Read ↗

Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaSemantic proximity Read ↗

Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.Semantic proximity Read ↗

Exploring Potential Drug Targets for Pancreatic Cancer Based on Mendelian RandomizationSemantic proximity Read ↗

Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis.Semantic proximity Read ↗

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read ↗

Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets and DNA Methylation-Mediated Regulation in Urological Malignancies.Semantic proximity Read ↗

DMRdb: a disease-centric Mendelian randomization database for systematically assessing causal relationships of diseases with genes, proteins, CpG sites, metabolites and other diseases.Semantic proximity Read ↗

Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genomeSemantic proximity Read ↗

Identifying Potential Drug Targets for Prostate Cancer from a Genetic Perspective: A Mendelian Randomization StudySemantic proximity Read ↗

The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug TargetingSemantic proximity Read ↗

Novel common target genes for breast cancer and colorectal cancer: A mendelian randomization and spatial transcriptomics studySemantic proximity Read ↗

Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.